Department of Leukemia, University of Texas M.D, Anderson Cancer Center, Houston, Texas, USA
Short Communication
Short Communication on Histone Modification Patterns using RPPA?Based Profiling Predict Outcome in Acute Myeloid Leukemia Patients
Author(s): Fieke W Hoff*, Ti'ara L Griffen, Anneke D van Dijk and Steven M Kornblau*
Acute Myeloid Leukemia (AML) is a hematological malignancy with poor survival outcomes in children and adults.
There is a need to enhance AML patient risk stratification to improve clinical outcomes. Precision medicine
approaches that focus on the identification of patient-specific biomarkers are currently in development to improve
diagnostics and treatment of cancer. Here, we comment on our studies showing the clinical significance of histone
and chromatin modifier proteins in AML. Using proteomics, we identified novel subsets of adult AML patients with
epigenetically distinct protein profiles that have clinical impact. More recently we discovered that overexpression of
similar proteins also seems to predict poor prognosis in pediatric AML, as well as that epigenetic proteins form
prognostic clusters in chronic lymphocytic leukemia. In this commentary we focus o.. View more»